The Financial Executives Edge · 2025-12-09 · 38 min
In this episode, we discuss America's most complex systems - our healthcare and pharmaceutical industries. From rising costs and drug pricing to employee benefits and AI/biotech breakthroughs, we unpack the forces shaping the care we depend on. We break down the root causes behind rising healthcare costs, how employers are grappling with rising insurance premiums, and discuss the role of HSAs and wellness incentives, and what this all means for employees. We also take listeners through the drug development lifecycle, from R&D to market, and candidly discuss the lack of pricing transparency. And as the episode unfolds, we will explore how AI and robotics are driving innovation, and how they are poised to redefine modern medicine. We dive into healthcare trends, reforms, affordability and the forces shaping healthcare. Ultimately, we ponder big questions: Can innovation and affordability truly coexist? and Is there a prescribed remedy for the broken healthcare system? Whether you work in healthcare, HR, or simply care about your own wellbeing, Vital Signs keeps you informed of what's ahead.
The Hidden Story of the AI Economy - Who Gets Taxed When No One Does the Work?86 / 100
The Illusion of Control: Cybersecurity, AI and the Risks Beneath the Surface72 / 100
AI in Finance: Driving Insights, FP&A & Financial Governance64 / 100
The AI-Enabled CFO: Governance, Data Integrity, Risk Oversight and Cybersecurity62 / 100
The AI-Enabled CFO80 / 100